先看重點
29名19-39歲的年輕人使用ANZEILAX-Green應用並配合智慧手錶8週後,GAD-7焦慮評分平均下降4.79分(95%置信區間-6.56至-3.02;P<.001)。研究沒有對照組,評分下降可能源於預期、時間等因素,而不一定是應用的作用。
證據類型
研究論文
解讀依據
公開摘要
閱讀重點
方法與適用範圍
研究在問什麼
許多年輕人有焦慮卻難以及時得到治療。能在當下詢問情緒的數字工具(生態瞬時評估與介入,EMA/EMI)可能有幫助,穿戴式資料又可使回饋更個性化。作者在真實環境中檢驗了ANZEILAX-Green的可行性與效果,該應用將EMA/EMI與智慧手錶的心率、睡眠和活動資料結合起來。
研究對象與方法
為期8週的探索性混合方法實驗研究,物件為19-39歲的年輕人,最終分析29人。參與者使用整合EMA/EMI模組的手機應用,並佩戴持續採集心率、睡眠和活動資料的智慧手錶。廣泛性焦慮障礙7項量表(GAD-7)和患者健康問卷-9(PHQ-9)在基線及第2、4、6、8週測量,羅森伯格自尊量表(RSES)在基線和第8週測量。變化用配對t檢驗和重複測量方差分析檢驗,訪談做主題分析。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1GAD-7平均下降4.79分(95%置信區間-6.56至-3.02;Cohen d=1.03;P<.001);PHQ-9下降3.86分(-5.79至-1.93;d=0.76;P<.001);RSES上升5.21分(3.47至6.95;d=1.14;P<.001)。
- 2GAD-7在各次評估中持續改善,自第4週起下降具有統計學意義。
- 3依從性高:參與者完成了80%的EMA/EMI提示。
- 4穿戴式資料顯示深睡眠增多、活動量減少的趨勢,睡眠指標與憂鬱症狀顯著相關。訪談歸納出5種機制:自我覺察增強、資料驅動的反思、行為改變、內在動機以及治療向日常生活延伸。
限制與不確定性
- 1沒有對照組,組內改善不能歸因於應用或穿戴式資料。
- 2僅29人納入分析,屬探索性設計;摘要未說明開始時有多少人,也未說明是否確診焦慮。
- 3焦慮和憂鬱靠問卷自評,且參與者知道自己在接受介入。
- 4作者指出這一效果需要對照試驗證實。本解讀僅基於摘要。
日常健康啟示
與智慧手錶配合的情緒打卡應用被這些年輕人較好地使用和接受,焦慮評分也下降了,但這不能證明是應用造成的。持續的焦慮問題應由臨床醫師或心理健康專業人員處理,而不是隻靠應用。
如何連結自己的資料
智慧手錶記錄了心率、睡眠和活動,8週內深睡眠和活動量有變化。如果你把情緒與睡眠、活動一起記錄,請使用同一裝置,看每週模式而不是單晚資料,並把睡眠與情緒的關聯當作可以討論的規律,而非診斷。
如何理解這類證據
索引未明確指出具體研究設計,應先讀方法;核對族群、對照、結果和不確定性,再判斷能否作因果解釋。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
Young adults report high levels of anxiety, yet their access to timely treatment remains limited. Mobile-based digital therapeutics, particularly ecological momentary assessment and intervention (EMA/EMI), offer a promising approach to deliver context-responsive care. The integration of wearable-derived digital phenotypes with digital therapeutics may enhance the personalization of feedback in such interventions, but empirical evidence from real-world settings remains scarce.
Objective
This study examined the real-world applicability and effectiveness of an EMA/EMI-based digital therapeutic, ANZEILAX-Green (HAII Corp), for use in anxiety reduction in young adults and investigated how personalized feedback generated by combining EMA/EMI data with wearable-based digital phenotypes ameliorates symptoms and promotes self-management and user engagement.
Methods
An 8-week exploratory experimental study was conducted with young adults aged 19-39 years. Participants used a smartphone app in which EMA/EMI modules had been integrated with a smartwatch that continuously collected digital phenotyping data, including heart rate, sleep, and activity. Psychological outcomes were assessed using the Generalized Anxiety Disorder 7-item scale (GAD-7) and Patient Health Questionnaire-9 (PHQ-9) at baseline and weeks 2, 4, 6, and 8, and the Rosenberg Self-Esteem Scale (RSES) at baseline and week 8. Quantitative changes were analyzed using paired-samples t tests and repeated-measures ANOVA, and qualitative interviews were thematically analyzed to identify user experience mechanisms and design implications.
Results
In all, 29 participants were included in the final analysis. Significant improvements were observed in their GAD-7 (mean difference -4.79, 95% CI -6.56 to -3.02; Cohen d=1.03; P<.001), PHQ-9 (mean difference -3.86, 95% CI -5.79 to -1.93; Cohen d=0.76; P<.001), and RSES scores (mean difference +5.21, 95% CI 3.47 to 6.95; Cohen d=1.14; P<.001). Consistent improvements in GAD-7 scores were observed across the assessment points, with statistically significant reductions from week 4 onward. Participants demonstrated high adherence, completing 80% of the EMA/EMI prompts. The digital phenotype showed trends of increased deep sleep and reduced mobility, and sleep indicators were significantly correlated with depressive symptoms. Analysis of the interview findings revealed 5 mechanisms: enhanced self-awareness, data-driven reflection, behavioral change, intrinsic motivation, and extension of treatment into daily life.
Conclusions
EMA/EMI-based digital therapeutics integrated with wearable-derived digital phenotypes are feasible and acceptable for use by young adults and were associated with within-group reductions in anxiety, suggesting acceptable efficacy, though this warrants confirmation in a controlled trial. The combination of real-time self-reported assessments of emotional states and passive physiological monitoring enables personalized feedback suited to users' emotional and physiological states. These findings offer empirical and design insights for automated, personalized mental health intervention systems.
來源與署名
Integration of Ecological Momentary Assessment and Intervention With Wearable-Based Digital Phenotypes to Treat Anxiety in Young Adults: Mixed Methods Experimental Study.
Song H, Choi Y, Park J, Hwang H, Kim J, Park C.
JMIR mHealth and uHealth · 2026-10-08
DOI: 10.2196/88919 ↗PubMed · 42849895 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
加速度計處理方法不同,身體活動與中風、心肌梗死的關聯曲線也不同
在英國生物銀行中,基線無心血管疾病的90237名成年人追蹤至2022年12月,共發生1298例中風和2031例心肌梗死;中高強度身體活動(MVPA)與這兩種結局的關聯曲線形狀,取決於加速度計資料的處理方法。就中風而言,只有機器學習法得到直線下降的風險;就心肌梗死而言,機器學習法和LFENMO法呈曲線下降,活動計數法呈直線下降。摘要沒有給出風險比,只能說明不同方法的結論不一致,不能說明哪種方法更正確,而且這些只是觀察性關聯。
Preventive Medicine
智慧手錶資料能當「證人」嗎:心率驗證得最充分,其餘證據參差
一項圍繞數字取證展開的系統評價和統合分析,梳理了四大主流品牌智慧手錶的驗證研究,發現心率是研究最多、也最準確的指標。步數、距離、能量消耗、活動分類和睡眠的驗證不夠一致,結果因品牌、方案和報告方式而異。摘要沒有給出彙總資料,且多數研究是在健康族群中、於實驗室內完成的,所以無法說明某一塊手錶對某個人在日常生活中的表現。
Forensic Science International
活動追蹤器:每天多走約1800步,對其他健康指標影響較小
這項傘形綜述彙總了39篇系統評價和統合分析,涉及163992名參與者;結果顯示使用活動追蹤器與身體活動增加相關(標準化均數差SMD為0.3–0.6),相當於每天多走約1800步、多步行40分鐘,體重減輕約1公斤。對血壓、膽固醇、糖化血紅蛋白、生活質量和疼痛的影響通常很小,且多數不顯著。摘要沒有說明這些專案裡追蹤器還搭配了什麼,也沒有說明各評價之間重疊多少,因此不能把效果完全歸功於裝置本身。
The Lancet Digital Health
七款睡眠追蹤裝置:識別睡著很準,識別醒著和睡眠分期較差
在睡眠實驗室裡,34名健康的年輕成年人連續三晚佩戴七款消費級睡眠追蹤裝置中的若干款。與多導睡眠監測相比,所有裝置識別睡眠都很準(靈敏度均不低於0.93),但識別清醒較差(特異度0.18–0.54),七款中有五款與研究用活動記錄儀(特異度0.39)持平或更好;睡眠分期的估計結果不穩定。受試者是18至35歲的健康成年人,臥床時間固定為8小時,每款裝置只在其中11至20人身上測試,因此對有睡眠問題的人幾乎沒有參考價值。
Sleep

